Literature DB >> 23180142

Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pK(a): implications for the design of mitochondrial probes and therapies.

Peter G Finichiu1, Andrew M James, Lesley Larsen, Robin A J Smith, Michael P Murphy.   

Abstract

Mitochondria play key roles in a broad range of biomedical situations, consequently there is a need to direct bioactive compounds to mitochondria as both therapies and probes. A successful approach has been to target compounds to mitochondria by conjugation to lipophilic cations, such as triphenylphosphonium (TPP), which utilize the large mitochondrial membrane potential (Δψ(m), negative inside) to drive accumulation. This has proven effective both in vitro and in vivo for a range of bioactive compounds and probes. However so far only neutral appendages have been targeted to mitochondria in this way. Many bioactive functional moieties that we would like to send to mitochondria contain ionisable groups with pK (a) in the range that creates an assortment of charged species under physiological conditions. To see if such ionisable compounds can also be taken up by mitochondria, we determined the general requirements for the accumulation within mitochondria of a TPP cation conjugated to a carboxylic acid or an amine. Both were taken up by energised mitochondria in response to the protonmotive force. A lipophilic TPP cation attached to a carboxylic acid was accumulated to a greater extent than a simple TPP cation due to the interaction of the weakly acidic group with the pH gradient (ΔpH). In contrast, a lipophilic TPP cation attached to an amine was accumulated less than the simple cation due to exclusion of the weakly basic group by the ΔpH. From these data we derived a simple equation that describes the uptake of lipophilic cations containing ionisable groups as a function of Δψ(m), ΔpH and pK(a). These findings may facilitate the rational design of additional mitochondrial targeted probes and therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180142     DOI: 10.1007/s10863-012-9493-5

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  23 in total

Review 1.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

2.  Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes.

Authors:  Carolyn M Porteous; Angela Logan; Cameron Evans; Elizabeth C Ledgerwood; David K Menon; Franklin Aigbirhio; Robin A J Smith; Michael P Murphy
Journal:  Biochim Biophys Acta       Date:  2010-06-08

3.  Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide.

Authors:  Anuradha Dhanasekaran; Srigiridhar Kotamraju; Chandran Karunakaran; Shasi V Kalivendi; Simmy Thomas; Joy Joseph; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2005-09-01       Impact factor: 7.376

4.  Potential antiradiation agents. I. Primary aminoalkanethiosulfuric acids.

Authors:  D L Klayman; M M Grenan; D P Jacobus
Journal:  J Med Chem       Date:  1969-05       Impact factor: 7.446

5.  A (99m)Tc-labeled triphenylphosphonium derivative for the early detection of breast tumors.

Authors:  Zhixin Li; Marcos Lopez; Micaël Hardy; Donna M McAllister; Balaraman Kalyanaraman; Ming Zhao
Journal:  Cancer Biother Radiopharm       Date:  2009-10       Impact factor: 3.099

6.  A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells.

Authors:  Bryan C Dickinson; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2008-07-08       Impact factor: 15.419

Review 7.  Roles of mitochondria in human disease.

Authors:  Michael R Duchen; Gyorgy Szabadkai
Journal:  Essays Biochem       Date:  2010       Impact factor: 8.000

Review 8.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

Authors:  Michael P Murphy; Robin A J Smith
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

9.  Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones.

Authors:  Abraham A Wube; Antje Hüfner; Christina Thomaschitz; Martina Blunder; Manfred Kollroser; Rudolf Bauer; Franz Bucar
Journal:  Bioorg Med Chem       Date:  2010-11-03       Impact factor: 3.641

10.  Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant.

Authors:  Jordi Asin-Cayuela; Abdul-Rahman B Manas; Andrew M James; Robin A J Smith; Michael P Murphy
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

View more
  17 in total

Review 1.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 2.  TPP-based mitocans: a potent strategy for anticancer drug design.

Authors:  Jiayao Wang; Jiaqi Li; Yumei Xiao; Bin Fu; Zhaohai Qin
Journal:  RSC Med Chem       Date:  2020-06-03

3.  Mitoquinol mesylate (MITOQ) attenuates diethyl nitrosamine-induced hepatocellular carcinoma through modulation of mitochondrial antioxidant defense systems.

Authors:  Rahmat Adetutu Adisa; Lateef Adegboyega Sulaimon; Ebele Geraldine Okeke; Olubukola Christianah Ariyo; Fatimah B Abdulkareem
Journal:  Toxicol Res       Date:  2021-11-08

4.  Insights on Targeting Small Molecules to the Mitochondrial Matrix and the Preparation of MitoB and MitoP as Exomarkers of Mitochondrial Hydrogen Peroxide.

Authors:  Andrew G Cairns; Stephen J McQuaker; Michael P Murphy; Richard C Hartley
Journal:  Methods Mol Biol       Date:  2021

5.  Anionic Polymers Promote Mitochondrial Targeting of Delocalized Lipophilic Cations.

Authors:  Ziwen Jiang; Hongxu Liu; Huan He; Nagendra Yadava; James J Chambers; S Thayumanavan
Journal:  Bioconjug Chem       Date:  2020-04-10       Impact factor: 4.774

6.  Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.

Authors:  Leonel A Cortes; Lorena Castro; Bárbara Pesce; Juan D Maya; Jorge Ferreira; Vicente Castro-Castillo; Eduardo Parra; José A Jara; Rodrigo López-Muñoz
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP.

Authors:  Mapa S T Mapa; Viet Q Le; Kandatege Wimalasena
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

8.  Mitochondrial Targeting of Antioxidants Alters Pancreatic Acinar Cell Bioenergetics and Determines Cell Fate.

Authors:  Jane A Armstrong; Nicole J Cash; Jack C Morton; Alexei V Tepikin; Robert Sutton; David N Criddle
Journal:  Int J Mol Sci       Date:  2019-04-05       Impact factor: 5.923

Review 9.  A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events.

Authors:  Alexandria N Hughes; Julia Thom Oxford
Journal:  Hepat Med       Date:  2014-03-06

10.  A mitochondria-targeted derivative of ascorbate: MitoC.

Authors:  Peter G Finichiu; David S Larsen; Cameron Evans; Lesley Larsen; Thomas P Bright; Ellen L Robb; Jan Trnka; Tracy A Prime; Andrew M James; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Biol Med       Date:  2015-10-08       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.